Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

80 is the new 60: implications of irrational exuberance regarding longevity on prostate cancer treatment decisions.

Freedland SJ, Walter LC.

J Gen Intern Med. 2012 May;27(5):485-6. doi: 10.1007/s11606-012-2006-8. No abstract available.

PMID:
22328015
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Comorbidities, treatment and survival.

Froehner M, Koch R, Wirth MP.

J Gen Intern Med. 2012 Oct;27(10):1240; author reply 1241. No abstract available.

PMID:
22782277
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comorbidities, treatment and ensuing survival in men with prostate cancer.

Chamie K, Daskivich TJ, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS.

J Gen Intern Med. 2012 May;27(5):492-9. doi: 10.1007/s11606-011-1869-4. Epub 2011 Sep 21.

PMID:
21935751
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Is diabetes mellitus associated with prostate cancer incidence and survival?

Will JC, Vinicor F, Calle EE.

Epidemiology. 1999 May;10(3):313-8.

PMID:
10230844
[PubMed - indexed for MEDLINE]
5.

Response to "Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size" (Int J Radiat Oncol Biol Phys 2011;79:1318-1322).

Tunio M, Hashmi A.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1195-6; author reply 1196. doi: 10.1016/j.ijrobp.2011.05.072. No abstract available.

PMID:
22036166
[PubMed - indexed for MEDLINE]
6.

[Mortality due to prostatic carcinoma in northern Sweden].

Damber JE, Grönberg H.

Urologe A. 1996 Nov;35(6):443-5. German.

PMID:
9064879
[PubMed - indexed for MEDLINE]
7.

Editorial comment to standard and saturation transrectal prostate biopsy techniques are equally accurate among prostate cancer active surveillance candidates.

Lee M.

Int J Urol. 2013 Sep;20(9):864-5. doi: 10.1111/iju.12076. Epub 2013 Jan 8. No abstract available.

PMID:
23294147
[PubMed - indexed for MEDLINE]
8.

Prognostic value of a new histologic classification of carcinoma of prostate.

Lee SS, Tseng CH, Hliang V, Guinan P.

Surg Forum. 1979;30:570-1. No abstract available.

PMID:
538698
[PubMed - indexed for MEDLINE]
9.

The prognostic significance of biopsies after radiotherapy for prostatic cancer.

Scardino PT.

Semin Urol. 1983 Nov;1(4):243-52. Review. No abstract available.

PMID:
6399610
[PubMed - indexed for MEDLINE]
10.

[Diagnostic value of tissue and serum prostate specific antigen in prostate cancer].

Medvedev VL.

Voen Med Zh. 2004 Feb;325(2):50-4. Russian. No abstract available.

PMID:
15101295
[PubMed - indexed for MEDLINE]
11.

Do the worst histological elements in needle biopsy specimens of prostate cancer predict prognosis?

Kubota Y, Kondo I, Harada M, Noguchi S, Hosaka M.

Lancet. 1996 Sep 21;348(9030):822-3. No abstract available.

PMID:
8813999
[PubMed - indexed for MEDLINE]
12.

[Localized prostate cancer].

Huland H.

Urologe A. 1991 Nov;30(6):345-7. German. No abstract available.

PMID:
1771714
[PubMed - indexed for MEDLINE]
13.

[Cytological diagnosis of the prostate].

Böcking A.

Urologe A. 1983 May;22(3):134-43. German.

PMID:
6192579
[PubMed - indexed for MEDLINE]
14.

[Epidemiologic and morphogenetic aspects of prostate cancer].

Dhom G.

Urologe A. 1991 May;30(3 Suppl):3-4. German. No abstract available.

PMID:
1746072
[PubMed - indexed for MEDLINE]
15.

Significant prognostic factor of immunohistochemical HER-2 expression using initial prostate biopsy specimens with M1b prostate cancer.

Tobiume M, Yamada Y, Nakamura K, Aoki S, Zennami K, Kato Y, Nishikawa G, Yokoi T, Honda N.

Prostate. 2011 Mar 1;71(4):385-93. doi: 10.1002/pros.21252. Epub 2010 Sep 1.

PMID:
20812221
[PubMed - indexed for MEDLINE]
16.

The Finnish trial of prostate cancer screening: where are we now?

Finne P, Stenman UH, Määttänen L, Mäkinen T, Tammela TL, Martikainen P, Ruutu M, Ala-Opas M, Aro J, Karhunen PJ, Lahtela J, Rissanen P, Juusela H, Hakama M, Auvinen A.

BJU Int. 2003 Dec;92 Suppl 2:22-6. No abstract available.

PMID:
14983949
[PubMed - indexed for MEDLINE]
17.

Prostate cancer therapy: a recipe for confusion.

See W.

Iowa Med. 1994 Jun;84(6):255-8. No abstract available.

PMID:
7520030
[PubMed - indexed for MEDLINE]
18.

Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy.

Taira AV, Merrick GS, Butler WM, Galbreath RW, Lief J, Adamovich E, Wallner KE.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1336-42. doi: 10.1016/j.ijrobp.2010.01.005. Epub 2010 Jun 3.

PMID:
20605342
[PubMed - indexed for MEDLINE]
19.

Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer.

Caso JR, Tsivian M, Mouraviev V, Polascik TJ, Moul JW.

BJU Int. 2010 Dec;106(11):1623-7. doi: 10.1111/j.1464-410X.2010.09439.x.

PMID:
20553260
[PubMed - indexed for MEDLINE]
20.

[Early diagnosis of prostate cancer].

Hocaoglu Y, Seitz M, Stief CG, Bastian PJ.

MMW Fortschr Med. 2012 Jan 19;154(1):43-6. German. No abstract available.

PMID:
22642003
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk